Savinkina A, Haass K, Sapiano M, Henry R, Berger J, Basavaraju S
Transfusion. 2020; 60 Suppl 2:S10-S16.
PMID: 32134123
PMC: 7908682.
DOI: 10.1111/trf.15654.
Prax M, Bekeredjian-Ding I, Krut O
Transfus Med Hemother. 2019; 46(2):76-86.
PMID: 31191193
PMC: 6514488.
DOI: 10.1159/000499349.
Levy J, Neal M, Herman J
Crit Care. 2018; 22(1):271.
PMID: 30367640
PMC: 6204059.
DOI: 10.1186/s13054-018-2212-9.
Prioli K, Karp J, Lyons N, Chrebtow V, Herman J, Pizzi L
Appl Health Econ Health Policy. 2018; 16(6):889-899.
PMID: 30062464
PMC: 6244623.
DOI: 10.1007/s40258-018-0409-3.
Jutzi M, Taleghani B, Rueesch M, Amsler L, Buser A
Transfus Med Hemother. 2018; 45(3):151-156.
PMID: 29928168
PMC: 6006633.
DOI: 10.1159/000489900.
Pathogen-reduced platelets for the prevention of bleeding.
Estcourt L, Malouf R, Hopewell S, Trivella M, Doree C, Stanworth S
Cochrane Database Syst Rev. 2017; 7:CD009072.
PMID: 28756627
PMC: 5558872.
DOI: 10.1002/14651858.CD009072.pub3.
Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India.
Chatterjee K, Zaman S, Chaurasia R, Singh S, Keil S, Tewari S
Asian J Transfus Sci. 2016; 10(2):127-31.
PMID: 27605849
PMC: 4993081.
DOI: 10.4103/0973-6247.187946.
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
Desborough M, Estcourt L, Doree C, Trivella M, Hopewell S, Stanworth S
Cochrane Database Syst Rev. 2016; (8):CD010982.
PMID: 27548292
PMC: 5019360.
DOI: 10.1002/14651858.CD010982.pub2.
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
Estcourt L, Desborough M, Hopewell S, Trivella M, Doree C, Stanworth S
Cochrane Database Syst Rev. 2016; 2015(6).
PMID: 26814707
PMC: 4699253.
DOI: 10.1002/14651858.CD011771.
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
Estcourt L, Desborough M, Hopewell S, Doree C, Stanworth S
Cochrane Database Syst Rev. 2015; (12):CD011771.
PMID: 26627708
PMC: 4755335.
DOI: 10.1002/14651858.CD011771.pub2.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Hopewell S, Trivella M, Murphy M
Cochrane Database Syst Rev. 2015; (11):CD010983.
PMID: 26576687
PMC: 4717525.
DOI: 10.1002/14651858.CD010983.pub2.
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P
Cochrane Database Syst Rev. 2015; (10):CD010984.
PMID: 26505729
PMC: 4724938.
DOI: 10.1002/14651858.CD010984.pub2.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Crighton G, Estcourt L, Wood E, Trivella M, Doree C, Stanworth S
Cochrane Database Syst Rev. 2015; (9):CD010981.
PMID: 26422767
PMC: 4610062.
DOI: 10.1002/14651858.CD010981.pub2.
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.
Keil S, Hovenga N, Gilmour D, Marschner S, Goodrich R
J Vis Exp. 2015; (102):e52820.
PMID: 26327141
PMC: 4692557.
DOI: 10.3791/52820.
Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.
Kleinman S, Stassinopoulos A
Transfusion. 2015; 55(12):2983-3000.
PMID: 26303806
PMC: 7169855.
DOI: 10.1111/trf.13259.
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722652
PMC: 4338578.
DOI: 10.1002/14651858.CD010984.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722651
PMC: 4338576.
DOI: 10.1002/14651858.CD010983.
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Gregg R, Stanworth S, Doree C, Trivella M, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722650
PMC: 4338548.
DOI: 10.1002/14651858.CD010982.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Crighton G, Wood E, Stanworth S, Trivella M, Doree C
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722649
PMC: 4338539.
DOI: 10.1002/14651858.CD010981.
One size will never fit all: the future of research in pediatric transfusion medicine.
Josephson C, Mondoro T, Ambruso D, Sanchez R, Sloan S, Luban N
Pediatr Res. 2014; 76(5):425-31.
PMID: 25119336
PMC: 4408868.
DOI: 10.1038/pr.2014.120.